Eclipse Breast Health Technologies: Bringing Breast Cancer Detection Home
Eclipse Breast Health Technologies is developing an inexpensive, at-home self-examination device to aid in the early detection of breast cancer. The noninvasive, handheld Eclipse device does not use radiation, and is completely painless so women can use it as often as they choose, without any risk of side effects.
Two recent recalls from the US FDA involve three deaths linked to an issue with an Abiomed heart pump — as well as three serious injuries related to angiographic catheters from Cook Medical.
Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.
The rate at which new documents to support the implementation of EU medtech regulations are issued has slowed of late; but June bucked the trend, with a flurry of activity.